✦ LIBER ✦

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

✍ Scribed by P Strojan; M Budihna; L Šmid; I Vrhovec; J Škrk

Book ID: 117665760
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 88 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00029-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of urokinase-type plasminogen activ

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

✍ E. Steiner; K. Pollow; D. Hasenclever; W. Schormann; M. Hermes; M. Schmidt; A. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 799 KB

Clinical relevance of urokinase-type pla

Clinical relevance of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral squamous cell carcinoma (OSCC)

✍ H.-F. Zeilhofer; K.P. Bock; P. Dettmar; B. Hundsdorfer; K. Ulm; R. Sader; H.-H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma

✍ Li Zhou; Yoshitake Hayashi; Takashi Itoh; Weiping Wang; Jing an Rui; Hiroshi Ito 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Transforming growth factor β1, urokinase

Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

✍ Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Background: A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to

Kinetics of inhibition of tissue-type an

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2

✍ Sixtus THORSEN; Malou PHILIPS; Johan SELMER; Ingegerd LECANDER; Birger ÅSTEDT 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Production of Urokinase-Type Plasminogen

Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours

✍ Y. Arai; T. Kubota; T. Nakagawa; M. Kabuto; K. Sato; H. Kobayashi 📂 Article 📅 1998 🏛 Springer Vienna 🌐 English ⚖ 333 KB